News

Competition in the AI image generator space is intense, with multiple companies like Ideogram, Midjourney and OpenAI hoping to convince you to use their offerings. That is why I'm a fan of NightCafe ...
Chinese artificial intelligence company iFlytek Co Ltd held an international symposium on multilingual large language models at the 2025 World AI Conference in Shanghai on Monday, as it advocates for ...
Claude 3, Gemini, Midjourney, and more with 1min.AI - now just $79.97 (reg. $540). AI is a circus, but you don't have to be its monkey. Between monthly fees, login juggling, and paying extra to access ...
With the new partnership, Bragi will offer headphone vendors the ability to access a GPT-based assistant via a button press or a wake word.
Colorado voters could weigh in on initiatives regarding immigration enforcement, college admissions, delivery fees and more.
The implications are far reaching. DeepSeek’s breakthrough prompts a complete rethinking of how AI infrastructure is ...
GLM-4.5’s launch gives enterprise teams a viable, high-performing foundation model they can control, adapt, and scale.
Z.ai’s new open-source models rank third globally, as the firm eyes a Hong Kong IPO and navigates around U.S. export controls ...
A massive AI data center proposed near Cheyenne, Wyoming, would use more electricity than all homes in the state combined.
OpenAI's ChatGPT-5 could drop in the coming days, and it could be one of the best models from the Microsoft-backed startup.
Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor ...